"Plunging into Endless Difficulties: Medicaid and Coercion in National Federation of Independent Business v. Sebelius," with N. Huberfield & E. W. Leonard, 93 Boston University Law Review 1 (2013).
"Agents Without Principals: Regulating the Duty of Loyalty for Non Profit Corporations Through the Intermediate Sanctions Tax Regulations," with C. B. Eisenberg, 5 Pepperdine Journal of Business Entrepreneurship & the Law 243 (2012).
Amici Curiae Brief on Behalf of the Department of Health and Human Services, DHHS v. Florida, U.S. Supreme Court No. 11-398 (Jan. 13, 2012). [ACA litigation, minimum coverage provision]
Amici Curiae Brief on Behalf of the Department of Health and Human Services, Florida v. DHHS, U.S. Supreme Court (Feb. 17, 2012). [ACA litigation, Medicaid expansion]
"Combatting Antibiotic Resistance Through the Health Impact Fund," with T. Pogge & A. Hollis, in The Globalization of Health Care: Legal and Ethical Issues Glenn I. Cohen, ed., Oxford University Press (2012).
"Deductions for Drug Ads? The Constitution Does Not Require Congress to Subsidize Direct-To-Consumer Prescription Drug Advertisements," with S. Speiser, 52 Santa Clara Law Review 453 (2012).
"Poverty Tourism, Justice, and Policy: Can Ethical Ideals Form the Basis of New Regulations?" E. Selinger & K. Whyte, 14 Public Integrity 39 (2011-12).
"Regulating Compounding Pharmacies after NECC," 367 New England Journal of Medicine 1969 (Nov 22, 2012).
"After the Deluge: Health Reform Without an Individual Mandate," with Austin Frakt, Kaiser Health News (Feb. 24, 2011).
Amici Curiae Brief on Behalf of the New England Journal of Medicine, the Massachusetts Medical Society, the National Physicians Alliance, and the American Medical Students Association in Sorrell v. IMS Health Inc., U.S. Supreme Court (March 1, 2011). [defending Vermont’s data mining law]
Blog Posts Incidental Economist (2011).
"Germ Shed Management in the United States," with Olga Yevtukhova, in Antibiotic Policies: Controlling Hospital Acquired Infection 163, I. M. Gould & J. van der Meer, eds., Springer (2011).
"Higher First Amendment Hurdles for Public Health Regulation," 365 New England Journal of Medicine e13 (2011).
"Improving Antibiotic Markets for Long Term Sustainability," with Aaron S. Kesselheim, 11 Yale Journal of Health Policy, Law & Ethics 101 (2011).
"Poverty Tourism and the Problem of Consent," with K. Whyte & E. Selinger, 7 Journal of Global Ethics 337 (2011).
"Smoking and the First Amendment," 365 New England Journal of Medicine 2351 (2011).
"Towards New Business Models for R&D for Novel Antibiotics," with A. D. So, et al., 14 Drug Resistance Updates 88 (2011).
"Disease-Based Limitations on Compulsory Licenses Under Articles 31 and 31bis," in Research Handbook on the Protection of Intellectual Property Under WTO Rules 673, Carlos Correa, ed., Edward Elgar Pub (2010).
"The Ethics of Poverty Tourism," with Evan Selinger, 7:2 Environmental Philosophy 93 (2010).
"Fighting Antibiotic Resistance: Marrying New Financial Incentives To Meeting Public Health Goals," with Aaron S. Kesselheim, 29 Health Affairs 1689 (2010).
"The Legal Ecology of Resistance: The Role of Antibiotic Resistance in Pharmaceutical Innovation," 31 Cardozo Law Review 613 (2010).
"Questions About the 10 x '20 Initiative," with J. H. Powers III, I. M. Gould & A. S. Kesselheim, 51 Clinical Infectious Diseases 751 (2010).
"Superbugs Call for Super Changes in Drug Sale Rules," with Kesselheim, Boston Globe A11 (Nov. 15, 2010).
Priority Watch List Treatment for Thailand and Brazil Under Section 182 of the Trade Act of 1974, submission to the United States Trade Representative Docket USTR-2009-0001 (Feb. 17, 2009).
Access to HPV Vaccines: Human Rights and Global Health, 35:2 & 3 American Journal of Law and Medicine, with F. Miller, editors (2009).
Amici Curiae Brief on Behalf of the New England Journal of Medicine, the Vermont Medical Society, the Massachusetts Medical Society, the New Hampshire Medical Society, the National Physicians Alliance, and the American Medical Students Association, in IMS, 2nd Circuit (2009).
Comments on the Physician Payment Sunshine Act of 2009, Submission to the U.S. Senate Committee on Aging (Jan. 26, 2009).
"Drug & Device Provisions in House Bill 3962," 15 PhRMA Pricing and Reimbursement 1 (Dec. 2009).
"The End of Reparations Talk? - Reparations in an Obama World," 57 Kansas Law Review 935 (2009).
"Foreword - Will HPV Vaccines Prevent Cervical Cancers Among Poor Women of Color?: Global Health Policy at the Intersection of Human Rights and Intellectual Property Law," 35 American Journal of Law & Medicine 247 (2009).
"From Comparative Effectiveness to Cost Effectiveness?" with Paige Goodwin, 14 PhRMA Pricing and Reimbursement 126 (May 2009).
"Global Pharmaceutical Markets," with Donald Light, in A Companion to Bioethics 417, 2d ed., H. Kuhse & P. Singer, eds., Blackwell (2009).
"How Medicare Could Get Better Prices on Prescription Drugs," with Aaron S. Kesselheim, 28 Health Affairs W832 (2009).
"Import Safety Rules And Generic Drug Markets," in Import Safety: Regulatory Governance in the Global Economy 110, C. Coglianese, A. Finkel & D. Zaring, eds., University of Pennsylvania Press (2009).
"Introduction: Pharmaceutical Innovation: Law & the Public's Health," in Symposium Pharmaceutical Innovation: Law & the Public's Health, 37 Journal of Law, Medicine & Ethics 173 (2009).
Pharmaceutical Innovation: Law & the Public's Health v.37:2 Journal of Law, Medicine & Ethics, editor (2009).
"Antibiotic Resistance and Antibiotic Development - Author's Reply," 8 Lancet Infectious Diseases 212 (2008).
"Market-Based Licenses for HPV Vaccines in Developing Countries," with Aaron S. Kesselheim, 27 Health Affairs 130 (2008).
"Should Access to Medicines and TRIPS Flexibilities Be Limited to Specific Diseases?" 34 American Journal of Law and Medicine 279 (2008).
"FDA Act Creates New Incentives for Tropical Diseases, Orphan Antibiotics," with Paige Goodwin, 12 PhRMA Pricing and Reimbursement 350 (2007).
"International Pharmaceutical Issues," in The Fundamentals of Life Sciences Law: Drugs, Devices, and Biotech 441, American Health Lawyers Association (2007).
"Will Longer Antimicrobial Patents Improve Global Public Health?" with J. B. Samora & K. Keller-Cuda, 7 Lancet Infectious Diseases 559 (2007).
Access to Global Disease Innovation, submission to WHO Intergovernmental Working Group (2006).
"Counterfeit Drugs: The Good, the Bad, and the Ugly," with Ryan Smith, 16 Albany Law Journal of Science & Technology 525 (2006).
"Fair Followers: Expanding Access to Generic Pharmaceuticals for Low- and Medium-Income Populations," in The Power of Pills: Social, Ethical and Legal Issues in Drug Development, Marketing and Pricing 164, J. C. Cohen, P. Illingworth & U. Schuklenk, eds., University of Michigan/Pluto Press (2006). Portuguese translation: 'Fair Followers': Expandindo o Acesso a Medicamentos Genericos para a Populacao de Baixa e Media Renda (2007).
"New Legislative Trends Threaten the Way Health Information Companies Operate," with Ilona Volker, 11 PhRMA Pricing and Reimbursement 324 (2006).
"Patent Buy-Outs for Global Disease Innovations for Low- and Middle-Income Countries," 32 American Journal of Law & Medicine 159 (2006).
"Agony in the Antipodes: The Generic Drug Provisions in the Australia - US Free Trade Agreement," 2 Journal of Generic Medicines 316 (2005).
"Pharmaceutical Arbitrage: Balancing Access and Innovation in International Prescription Drug Markets," 5 Yale Journal of Health Policy, Law & Ethics 193 (2005).
"Tragedy & Remedy: Reparations for Disparities in Black Health," 9 DePaul Journal of Health Care Law 735 (2005).
"The Transparency Revolution in PhRMA Pricing," 10 PhRMA Pricing and Reimbursement 4 (2005).
"The Vanishing Public Domain: Antibiotic Resistance, Pharmaceutical Innovation and Global Public Health," 67 University of Pittsburgh Law Review 67 (2005).
"Free Trade Against Free Riders?" 9 PhRMA Pricing and Reimbursement 254 (2004).
"Free Trade in Pharmaceuticals," 181 Medical Journal of Australia 260 (2004).
"Medicare Act (1965)," in 2 Major Acts of Congress 264, Brian K. Landsberg, ed., MacMillan (2004).
"More Questions Than Answers: A Quick Response to the USTR Press Release on the AUSFTA," www.citizenstrade.org (2004).
"Pharma Under George III," 9 PhRMA Pricing and Reimbursement 352 (2004).
"Prohibition of the Slave Trade (1807)," in 3 Major Acts of Congress 138, Brian K. Landsberg, ed., MacMillan (2004).
"Rapid Response to Editorial," British Medical Journal (Jun 23, 2004). Commenting on: P. Drahos & D. Henry, "The Free Trade Agreement Between Australia and the United States," 328 British Medical Journal 1271 (May 2004).
Amicus Brief on Behalf of Respondents in Gratz v. Bollinger and Grutter v. Bollinger on behalf of the National Coalition of Blacks for Reparations in America and the National Conference of Black Lawyers, U.S. Supreme Court (Feb. 14, 2003). [the Michigan affirmative action cases]
"Slave Taxes," in Should America Pay?: Slavery and the Raging Debate over Reparations 135, Raymond Winbush, ed., Harper Collins (2003). Reprinted in Studies in the History of Tax Law 263, John Tiley, ed., Hart Publishing (2004).
"GP Corporatisation: Lessons Learned from the U.S. Experience," 175:8 Medical Journal of Australia 426 (2001).
"Disease Management: Legal Strategies for the Next Generation of Managed Care," with Butler, 31 Journal of Health Law 291 (1998). Updated and republished as Disease Management and Gainsharing: The Next Generation of Managed Care, with Miley and Butler, 2d ed., AHLA Monograph (1999).
"Revenue Procedure 91-12: The IRS Launches an Information-Gathering Offensive Against International Transportation Operations," with Cheung, 91 Tax Notes International 71 (1991).
"Taxation Without Premeditation: An Economic Analysis of the Structure, Regulation and Strangulation of the Private Activity Bond Market," 6 Boston University Journal of Tax Law 1 (1988).